drugset / Trial / NCT03592277
Vitamin C & Thiamine to Treat Sepsis and Septic Shock
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Investigators propose to investigate the use of IV vitamins B1 and C in a randomized, double-blinded, prospective trial to determine if these medications decrease mortality rates in patients with severe sepsis or septic shock.
Timeline
- Start
- 2018-09-14
- Primary completion
- 2021-02-22
- Completion
- 2021-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thiamine | Other / unclassified | 200 mg | Intravenous |
| Subject | Vitamin C | Other / unclassified | 1.5 g | Intravenous |